killed escherichia coli k12
Vaccineexperimental
Clinical trial activity
1 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2015 (NCT00548054)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Escherichia coliImmunity, active
Escherichia coli immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- killed escherichia coli k12
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00548054 | Phase 2 | Dec 1, 2015 | Indian Council of Medical Research, International Vaccine Institute, National Institute of Cholera and Enteric Diseases, Kolkata, India, National Institutes of Health (NIH), Shantha Biotechnics Limited |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Indian Council of Medical Research | Academic/Hospital | 1 | 0 | 1 | 2015 |
| International Vaccine Institute | Academic/Hospital | 1 | 1 | 1 | 2015 |
| National Institute of Cholera and Enteric Diseases, Kolkata, India | Academic/Hospital | 1 | 0 | 1 | 2015 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 2015 |
| Shantha Biotechnics Limited | For profit | 1 | 0 | 1 | 2015 |
5 organizations
Page 1 / 1